Nurix Therapeutics (NRIX) Interest & Investment Income (2019 - 2026)
Nurix Therapeutics (NRIX) reported Interest & Investment Income of $5.3 million for Q1 2026, down 18.3% year-over-year from $6.5 million in Q1 2025, and up 9.17% quarter-over-quarter from $4.9 million in Q4 2025.
Nurix Therapeutics (NRIX) Interest & Investment Income (2019 - 2026) Analysis & Trends
Nurix Therapeutics (NRIX) has 8 years of Interest & Investment Income data on file, last reported at $5.3 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $5.3 million, down 18.3% year-over-year; the trailing twelve-month figure through Feb 2026 was $20.8 million (down 7.45% YoY), and the FY2025 annual result was $22.0 million, up 11.36% from the prior year.
- Interest & Investment Income rose to $5.3 million in Q1 2026 per NRIX's latest filing, from $4.9 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $6.5 million in Q1 2025 and troughed at $211000.0 in Q1 2022.
- A 5-year average of $3.6 million and a median of $3.8 million in 2024 frame the typical range for Interest & Investment Income.
- On a YoY basis, Interest & Investment Income climbed as much as 2487.18% in 2022 and fell as far as 33.65% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at $2.0 million in 2022, then soared by 71.21% to $3.4 million in 2023, then soared by 81.05% to $6.1 million in 2024, then fell by 20.31% to $4.9 million in 2025, then climbed by 9.17% to $5.3 million in 2026.
- Business Quant data shows NRIX's Interest & Investment Income at $5.3 million in Q1 2026, $4.9 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Nurix Therapeutics | 1.93 Bn | 1.39 Bn | - | 5.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 5.32 Mn |
| Nov 30, 2025 | 4.87 Mn |
| Aug 31, 2025 | 4.96 Mn |
| May 31, 2025 | 5.62 Mn |
| Feb 28, 2025 | 6.51 Mn |
| Nov 30, 2024 | 6.12 Mn |
| Aug 31, 2024 | 5.74 Mn |
| May 31, 2024 | 4.08 Mn |
| Feb 29, 2024 | 3.79 Mn |
| Nov 30, 2023 | 3.38 Mn |
| Aug 31, 2023 | 3.03 Mn |
| May 31, 2023 | 2.49 Mn |
| Feb 28, 2023 | 2.22 Mn |
| Nov 30, 2022 | 1.97 Mn |
| Aug 31, 2022 | 1.01 Mn |
| May 31, 2022 | 314,000.00 |
| Feb 28, 2022 | 211,000.00 |
| Nov 30, 2021 | 295,000.00 |
| Aug 31, 2021 | 39,000.00 |
| May 31, 2021 | 171,000.00 |